 |
 |
|
BIOCHIMIE
| |
| | |
|
|
An International Journal of Biochemistry and Molecular Biology
Published under the auspices of the Société Française de Biochimie et Biologie Moléculaire.
|
|
|
|
Guide for Authors
BIOCHIMIE
The International Journal of the French Society for Biochemistry and Molecular Biology
Published under the
auspices of the Societe Francaise de Biochimie et Biologie Moléculaire.
Guide for Authors
Biochimie
is an English language, multi-topical journal publishing original articles, short communications, as well as review articles in all areas
of biology (enzymology, genetics, immunology, microbiology, structure of macromolecules, etc), provided that the approach adopted stems
from biochemistry, biophysics or molecular biology.
Publication types
Original Research articles
Short communications
Review articles and mini-reviews
Hypotheses
Letters to the Editor, commenting on papers published in Biochimie
Manuscript submission
Manuscripts should be submitted to the Biochimie web site at  http://ees.elsevier.com/biochi.
Submission is only possible online through this web site. Authors are required to transmit the text and art of the manuscript in electronic
form to this address. A manuscript is accepted for consideration for publication in Biochimie with the understanding that it
has not been published previously (except in abstract form or as part of a public lecture or academic thesis), that it is not under consideration
for publication elsewhere, that its publication has been approved by all the authors and tacitly or explicitly by the responsible authorities
in the laboratories where the work was carried out and that, if accepted, it will not be published elsewhere in the same form, in either
the same or another language, without the consent of the Editors and the Publisher. Reference should be made to previously published
abstracts, etc. in the introductory section. Responsibility for the accuracy of the material in the manuscript, including bibliographic
citations, lies entirely with the authors. Relevant ethical approval must be noted for investigations involving human or animal subjects.
Authors are invited to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed
paper.
A submission letter should always accompany the submitted paper, providing the following information:
(a) The full
name and address of the corresponding author (including telephone and fax numbers and E-mail address).
(b) Any known changes of address
within a period of six months after submission of the paper.
(c) The type of paper (Original Research article, Short communication,
Review article, Letter to the Editor, etc).
(d) The full title of the submitted paper.
(e) The names, addresses and telephone,
fax and e-mail details (where possible) of five suitable, potential reviewers. If there are compelling reasons for excluding some individuals
as potential reviewers, these may be mentioned. However, the ultimate reviewer selection is at the Editor's discretion.
We assume
that all of the authors have approved the submitted manuscript. If this assumption turns out to be incorrect, the manuscript will be
withdrawn and will not be published.
Closely related papers that are in press or that have been submitted elsewhere must be included
with the manuscript.
Submitted manuscripts will generally be published within a week of acceptance and thus be made public.
The Editors are responsible for the professional review of the manuscripts. Receipt of manuscripts by the journal will be acknowledged.
Language Editing
If English is not your native language, authors may wish have their manuscript checked by someone
proficient in the language. Manuscripts in which the English is difficult to understand may be returned to the author for revision before
scientific review. The external services offered on our website are for your consideration only: http://www.elsevier.com/locate/languagepolishing
For all third party language editing recommendations, all interaction and responsibility is between the Author and the Language Editor.
Language editing should not be confused with the copy-editing that takes place during the production process after a manuscript has been
accepted.
Ethics of Experimentation
Scientific investigations involving humans or animals must have approval of the
appropriate ethics committee. When conducting scientific research using human tissue and which is intended for publication in Biochimie,
authors should follow procedures that are in accordance with the ethical standards as formulated in the Helsinki Declaration of 1975
(revised 1983). When conducting experiments on animals, these be carried out in accordance with the EU (86./609/EEC), NIH guidelines,
or local or national requirements for the care and use of laboratory animals. A statement that informed consent was obtained from all
subjects must accompany investigations involving humans
Revision and publication dates
Manuscripts requiring revision
and/or condensation will be returned to the authors by the Editor, specifying the requested alterations and including the (anonymous)
referee reports. Authors are requested to resubmit the revised manuscript within three months. Papers not resubmitted within three months
will be treated as new submissions.
Proofreading
Proofs will be sent to the corresponding author of an article by
email in a PDF file. The proof should be checked carefully and corrections (including replies to a Query Form) should be returned in
an e-mail to Elsevier using the "reply" button within 2 days of receipt. As acceptance is based upon the submitted version of the paper,
it is essential that no new material be inserted in the text at the time of proofreading; furthermore, no alterations to style or meaning
will be permitted at this stage. Any new material that the authors may wish to introduce, for reasons of scientific accuracy, will be
checked by the Editor and a charge may be made for corrections. Elsevier will do everything possible to get your article corrected and
published as quickly and accurate as possible. Therefore, it is important to ensure that all of your corrections are sent back to us
in one communication. Important to note: Subsequent corrections will not be possible, so please ensure your first sending is complete.
Page charges
There are no submission fees or page charges
Publication
For enquiries relating to
the submission of articles please visit the journal's homepage at http://www.elsevier.com/locate/biochi or http://ees.elsevier.com/biochi/.
From there you can also track accepted articles ( http://www.elsevier.com/trackarticle) and set up e-mail alerts to inform
you of when an article's status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions
and more.
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided
after registration of an article for publication.
PREPARATION OF PAPERS
Authors should consult a recent issue of
the journal to make themselves familiar with the conventions and layout of articles.
The entire text, including figure and table
legends and the reference list, should be double-spaced, leaving margins of approximately 3 cm (1 inch). All pages should be numbered
consecutively and carry a running title, in the upper right corner, starting with the title page of the manuscript. Every new paragraph
should be clearly indented. Do not use right-hand justification.
Title page
Page 1 should be concise, descriptive
and informative. It should include:
(1) The title of the article;
(2) The authors' full names (first name, middle initial(s),and
surname);
(3) Affiliations (the name of department (if any), institution, city and state or country where the work was done), indicating
which authors are associated with which affiliation;
(4) Acknowledgement of grant support and of individuals who were of direct help
in the preparation of the study;
(5) Disclaimers, (if any);
(6) The name, address, telephone and fax numbers and E-mail address
of the corresponding author Authors are requested to select a maximum of 5 key words and to present them on the title page of the typescript.
They should cover precisely the contents of the submitted paper and should give readers sufficient information as to the relevance of
the paper to his/her particular field.
Abstract
Page 2 of the typescript should be reserved for the Abstract which
should have no more than 300 words. Since summaries are increasingly used by abstracting services which will cut off after a fixed number
of words, it is important not to exceed the maximum number of words and to avoid bibliographic references and non-standard abbreviations.
Text
After the Abstract, Original Research Articles should be organized in the following format: Introduction, Materials
and methods, Results, Discussion, Acknowledgements, List of abbreviations, References
Introduction This is a short section
in which the authors should clearly state the reasons for and aims of the investigation. Summarise the rationale for the study and hypothesis
tested by it, with brief reference to relevant previous work.
Materials and methods The section Materials and methods should
be detailed enough for readers to reproduce the experiments. Where possible, reference should be made to previously published methodology,
with mention only of significant experimental differences. Conclusions drawn from experiments described in the tables or figures can
often appear most conveniently in the Results section.
Result and Discussion The overall conclusions based on the work reported
should be given in the Discussion. In some cases, Results and Discussion sections may more appropriately be combined than separated (at
the author's discretion). Every effort should be made to avoid jargon, to spell out all non-standard abbreviations the first time they
are mentioned and to present the contents of the study as clearly and concisely as possible.
Short Communications should
be a maximum of 4 printed pages (approx. 2,500 words) maximum, including title, references, and only 2 figures or tables and will
be rejected if submitted in excess of this length.
Reports of new or improved methods should be as brief as is consistent with
clarity (up to about 1,000 words). They should unequivocally identify the element of novelty claimed and the advantages over existing
technology. Performance characteristics, including effects of interfering substances, comparisons with results of accepted methods and
reference values based on appropriate population samples should be documented by adequate data. Citing of earlier publications is preferred
to repetition of details for reagents, procedures, etc., which are always in print. Nevertheless, the information provided must suffice
to allow readers to duplicate the work or to compare the technique with current practice.
Acknowledgements
Only persons
who have made substantial contributions to the work should be acknowledged. Authors are responsible for obtaining written permission
from everyone acknowledged by name because readers may infer their endorsement of the data and conclusions. The source(s) of support
in the form of grants, equipment, drugs, or all of these should be acknowledged here.
References
Type references double-spaced
and number them consecutively in the order in which they are first quoted in the text. Identify references in text, tables and legends
by arabic numerals [square brackets]. References cited only in tables or in legends to figures should be numbered in accordance with
a sequence established by the first identification in the text of the particular table or illustrations. Please note that all authors
should be listed when six or less; when seven or more, list only the first three and add et al. The names of journals should be abbreviated
according to the list of serial title word abbreviations (ISDS, Paris, l985, ISBN 2-904938-02-8). Do not include references to personal
communications, unpublished data or manuscripts either 'in preparation' or 'submitted for publication'. Reference to a paper as 'in press'
implies that it has been accepted for publication. Recheck references in the text against the reference list after your manuscript has
been revised and renumber accordingly. Incomplete references can result in publication delay.
Examples of correct forms of references
are as follows:
[1] M.M. Mathews-Roth, Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases,
Biochimie 68 (1986) 875-884.
[2] K. Folkers, Y. Yamamura, Biomedical and Clinical Aspects of Coenzyme Q, Elsevier, Amsterdam,
Vol. 4, 1984, 432 p.
[3] P. Druet, J.F. Bernaudin, D.R. Davies, R. Mancilla-Jimenez, B. Belon, J. Bariety, Enzymes and antienzymes
as tracers in biology, in: J. Avrameas, P. Druet, R. Masseyeff, G. Feldman (Eds.), Immunoenzymatic Techniques, Elsevier, Oxford, 1983,
pp. 300-306.
Tables
Tables should be used sparingly; they should be used only when the data cannot be presented clearly
in the text. Each table, and every column should be provided with an explanatory heading, with units of measure clearly indicated. The
heading of the table should make its general meaning understandable without reference to the text. Authors are requested to consult recent
issues of Biochimie for the proper table layout. Cite each table in the text in consecutive order. The Editor-in-Chief, on accepting
a manuscript, may recommend that additional tables containing important backup data, too extensive to be published in the article, may
be published as supplementary material (see below) or deposited with the National Auxiliary Publications Service or made available by
the author(s). In that event, an appropriate statement will be added to the text. Submit such tables for consideration with the manuscript.
Figures
Figures should be used to illustrate experimental results clearly. Illustrations for reproduction should normally
be about twice the final size required as figures are often reduced to a one-column width. Symbols, lettering and lines should be sufficiently
large and clear to be legible after reduction. Photographs of tissues, cells, or subcellular components should be included only when
they are essential. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Colour Figures
Colour figures may be included in the article in the printed issue, but generally this expense must be
borne by the authors. However, if, together with your accepted article, you submit usable colour figures, then Elsevier will ensure,
at no additional charge, that these figures will appear in colour on the Web (e.g., ScienceDirect and other sites) regardless of whether
these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding
the costs from Elsevier after receipt of your accepted article. For more detailed instructions please visit our artwork instruction pages
at http://www.elsevier.com/artworkinstructions. [Please note: Because of technical complications that can arise in converting
colour figures to "grey scale" (for the printed version should you not opt for colour in print), please submit in addition usable black-and-white
files corresponding to all the colour illustrations.]
Figure Legends
Legends should be collated, typed double-spaced,
numbered with Arabic numerals corresponding to the illustrations, and submitted on a separate page. When symbols, arrows, numbers, or
letters are used to identify parts of the illustrations, each should be explained clearly in the legend. For photomicrographs, the internal
scale markers should be defined and the method of staining should be given. The legends should permit the figures to be understood without
reference to the text. If the figure has been previously published, a credit line should be included and a permission letter supplied
by the author. As only one figure caption may be used for both colour and black and white versions of figures, please ensure that figure
captions are meaningful for both versions, if applicable.
Figure legends should be provided as text, placed after the reference
section in the main manuscript file. Number figures consecutively with Arabic numerals. When creating your figures, use font sizes and
line weights that will reproduce clearly and accurately when figures are sized to the appropriate column width. The minimum line weight
is 0.5 point. Thinner lines will not reproduce well. Eliminate all excess white space from the borders of each figure. Do not include
figure legends or other extraneous text in a graphic file. For more detailed instructions please visit our artwork instruction pages
at http://www.elsevier.com/artworkinstructions.
Quantities and units
These should be in conformity with
international practice relating to the use of SI units: thus concentrations of solutes of known molecular mass should normally be stated
in mol/l or recognized submultiples thereof (nmol/l, etc.). Other solutes should be expressed in g/l, mg/l, etc. Reagent composition
may be specified either in molar terms or in mass or volume of each solute per liter of final solution (% or w% should not be used).
Enzyme activities should be reported in katals or U/l whenever possible and should be accompanied by a reference to, or a description
of, the procedure used for the measurements.
PREPARATION OF SUPPLEMENTARY MATERIAL
Elsevier accepts electronic supplementary
material to support and enhance your scientific research. Supplementary files offer additional possibilities for publishing supporting
applications, movies, animation sequences, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied
will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect ( http://www.sciencedirect.com).
For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
PUBLICATION
Copyright Transfer: Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement"
(for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author confirming receipt of
the manuscript together with a "Journal Publishing Agreement" form or a link to the online version of this agreement.
E-Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 25 free paper offprints.
The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer
outlining the terms and conditions of use.
ELSEVIER FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established
agreements and developed policies to allow authors who publish in Elsevier journals to comply with manuscript archiving requirements
of many funding bodies, as specified as conditions of researcher grant awards. These agreements and policies enable authors to comply
with their funding body's archiving policy without having to violate their publishing agreements with Elsevier. The agreements and policies
are intended to support the needs of Elsevier authors, editors and society publishing partners, and to protect the quality and integrity
of the peer-review process. More details may be found on the web sites: http://www.elsevier.com/wps/find/authorsview.authors/fundingbodyagreements
http://www.elsevier.com/wps/find/authorshome.authors/nihauthorrequest
Author's rights
As an author you
(or your employer or institution) may do the following:
make copies (print or electronic) of the article for your own personal use,
including for your own classroom teaching use;
make copies and distribute such copies (including through e-mail) of the article
to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g., via an e-mail list or
list server);
post a pre-print version of the article on Internet websites including electronic pre-print servers, and to retain
indefinitely such version on such servers or sites;
post a revised personal version of the final text of the article (to reflect
changes made in the peer review and editing process) on your personal or institutional website or server, with a link to the journal
homepage (on elsevier.com);
present the article at a meeting or conference and to distribute copies of the article to the delegates
attending such a meeting;
for your employer, if the article is a 'work for hire', made within the scope of your employment, your
employer may use all or part of the information in the article for other intra-company use (e.g., training);
retain patent and trademark
rights and rights to any processes or procedure described in the article;
include the article in full or in part in a thesis or
dissertation (provided that this is not to be published commercially);
use the article or any part thereof in a printed compilation
of your works, such as collected writings or lecture notes (subsequent to publication of your article in the journal);
prepare other
derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full
acknowledgement of its original publication in the journal.
Updated July 2008 - for the latest version please check the journal's
web site: http://www.elsevier.com/locate/biochi
US National Institutes of Health (NIH) voluntary posting (?Public
Access?) policy.
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH ?Public Access
Policy?; see http://www.nih.gov/about/publicaccess/index.htm ) by posting the author?s peer-reviewed manuscript directly
to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will
ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com that your work has received NIH funding
and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation,
Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting
12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need
for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.
|
|
|
|
| |
| | |
|
| |
